The National Health Service (NHS) is set to trial ultra-fast brain scanning technology aimed at accelerating the diagnosis of dementia. Researchers involved in the initiative believe the new scans can reduce the time patients spend in an MRI scanner from approximately 20 minutes to just six, without compromising the quality or completeness of the diagnostic data collected.

This reduction of nearly 70 percent in scan duration is expected to enhance patient experience by making the imaging process quicker and more tolerable. It may also increase access to MRI scanning, lower operational costs, and help manage growing demand for dementia assessment services.

The ultra-fast scans form part of a broader £80 million NHS project testing nine new technologies designed to speed up dementia diagnosis and improve patient outcomes. Currently, only about 60 percent of patients receive a diagnosis within 18 weeks of referral, with some waiting more than a year for results. The NHS has set a target to increase this figure to 92 percent.

Led by University College London, the trial involves collaboration with major MRI manufacturers including Philips, Siemens, and GE. Testing will take place across 20 NHS sites, providing a range of clinical settings to evaluate the technology’s effectiveness and feasibility within the healthcare system.

Alzheimer’s Research UK’s Hilary Evans-Newton emphasized the importance of this initiative, highlighting the potential to transform the diagnostic pathway and reduce delays for patients experiencing symptoms of dementia.

If successful, the implementation of ultra-fast brain scans could represent a significant advancement in the early detection and treatment of dementia, with broader implications for healthcare delivery and patient care standards within the NHS.